Description

Cinnarizin Sofarma (Cinnarizinum) tablets 25 mg. №50

Ingredients:

Each tablet contains 25 mg of Cinnarizinum as the active ingredient.

Dosage:

The usual dose for adults is 25 mg (1 tablet) three times a day.

Indications:

Cinnarizinum is indicated for the treatment of vertigo, Meniere’s disease, and motion sickness.

Contraindications:

Do not use Cinnarizinum if you are allergic to cinnarizine or any other ingredients in the tablets.

Directions:

Swallow the tablets whole with a glass of water. Do not crush or chew the tablets.

Scientific Evidence:

Cinnarizinum is a calcium channel blocker with antihistaminic properties that help in the management of vertigo and motion sickness. Studies have shown that cinnarizine effectively reduces the severity and frequency of vertigo episodes by its action on the vestibular system.

Additional Information:

Cinnarizinum has been widely used in clinical practice for its efficacy in treating vestibular disorders. It has a good safety profile with minimal side effects, making it a preferred choice for patients with vertigo and motion sickness. Consult your healthcare provider for personalized recommendations.